< Back to companies

OncoVerity is a mission-driven healthcare startup focused on transforming cancer treatment through the application of computational tools to clinical and biological data. The company, comprised of experienced professionals from various sectors including academia, the clinic, and industry, recognizes the complexity of cancer as a multifaceted disease that affects individuals differently. They aim to develop therapies that instill hope and improve outcomes for cancer patients. Their current research includes clinical trials, such as evaluating Cusatuzumab combined with azacitidine for patients with newly diagnosed acute myeloid leukemia (AML) and investigating the interactions of nasopharyngeal carcinoma cells that affect regulatory T cell development.

Share
Shareable draft
Get Involved in OncoVerity

Company Info

Founded
2022
Website
www.oncoverity.com/

Categories

Cancer CareDrug DevelopmentResearch, Evidence & KnowledgeLife Sciences

Technologies

Computational ToolsData AnalysisBiotechnologyAI/Machine Learning
Only accessible to MedStartr community members. Join now

What do you think of OncoVerity?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in OncoVerity
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free